M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Leap Therapeutics, Inc. to acquire Flame Biosciences
Announced Jan 17, 2023 · Closed Jan 17, 2023 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Leap Therapeutics, Inc. (LPTX)
- Target
- Flame Biosciences
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jan 17, 2023
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Raymond James
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations